CLBT
The table below shows Cellebrite DI Ltd.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $475.68M | $401.20M | $325.11M | $270.65M | $246.25M | $194.91M |
| Cost of revenue | $75.17M | $62.59M | $53.23M | $50.75M | $42.56M | $37.88M |
| Gross profit | $400.50M | $338.61M | $271.88M | $219.91M | $203.69M | $157.03M |
| R&D | $113.88M | $98.42M | $84.39M | $80.62M | $65.54M | $54.38M |
Cellebrite DI Ltd. reported annual revenue of $475.68M for fiscal year 2025. That is up 18.6% from $401.20M in fiscal 2024. Over the 7 fiscal years shown, annual revenue grew from $171.85M (FY 2019) to $475.68M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $65.33M |
| $50.90M |
| $43.44M |
| $40.85M |
| $47.94M |
| $32.13M |
| Operating income | $66.48M | $56.91M | $33.24M | $1.04M | $13.82M | $9.22M |
| Income tax | $12.35M | $7.02M | $5.54M | -$45.00K | $10.91M | $5.62M |
| Net income | $78.33M | -$283.01M | -$81.10M | $120.81M | $71.40M | $5.78M |
| EPS (diluted) | $0.31 | -$1.35 | -$0.43 | $0.59 | $0.44 | -$0.08 |